
<!DOCTYPE html>
<html lang="en-US">
<head>
<meta charset="UTF-8" />
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1234567890123456" crossorigin="anonymous"></script>
<meta name="author" content="David Li" />
<meta name="generator" content="LaTeX Lwarp package" />
<meta name="description" content="Publicly available stonk research from me." />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<!--[if lt IE 9]>
<script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<title>Stonk Research — Bloom Health</title>
<link rel="stylesheet" type="text/css" href="lwarp_sagebrush.css" />
</head>
<body>


<a id="lwarp_template-autopage-51"></a>
<nav class="topnavigation"><a href="lwarp_template.html" class="linkhome" >
Home</a></nav>


<div class="bodyandsidetoc">
<div class="sidetoccontainer">


<nav class="sidetoc">


<div class="sidetoctitle">

<p>
<span class="sidetocthetitle">Stonk Research</span>
</p>

<p>
Contents
</p>
</div>


<div class="sidetoccontents">

<p>
<a href="lwarp_template.html" class="linkhome" >
Home</a>
</p>

<p>
<a href="Stonk-Picks.html#autosec-6" class="tocchapter" >
<span class="sectionnumber">1</span>&#x2003;Stonk Picks</a>
</p>


<p>
<a href="Stonk-Picks.html#autosec-7" class="tocsection" >
<span class="sectionnumber">1.1</span>&#x2003;EarthRenew</a>
</p>


<p>
<a href="Research.html#autosec-10" class="tocchapter" >
<span class="sectionnumber">2</span>&#x2003;Research</a>
</p>


<p>
<a href="Research.html#autosec-11" class="tocsection" >
<span class="sectionnumber">2.1</span>&#x2003;2022</a>
</p>


<p>
<a href="Green-Hydrogen.html#autosec-24" class="tocsection" >
<span class="sectionnumber">2.2</span>&#x2003;Green Hydrogen</a>
</p>


<p>
<a href="Fertilizer-CleanTech.html#autosec-26" class="tocsection" >
<span class="sectionnumber">2.3</span>&#x2003;Fertilizer and CleanTech</a>
</p>


<p>
<a href="Valuations.html#autosec-29" class="tocchapter" >
<span class="sectionnumber">3</span>&#x2003;Valuations</a>
</p>


<p>
<a href="Valuations.html#autosec-30" class="tocsection" >
<span class="sectionnumber">3.1</span>&#x2003;Earthrenew</a>
</p>


<p>
<a href="Peak-Fintech.html#autosec-36" class="tocsection" >
<span class="sectionnumber">3.2</span>&#x2003;Peak Fintech</a>
</p>


<p>
<a href="ZIM.html#autosec-38" class="tocsection" >
<span class="sectionnumber">3.3</span>&#x2003;ZIM</a>
</p>


<p>
<a href="FGI.html#autosec-40" class="tocsection" >
<span class="sectionnumber">3.4</span>&#x2003;FGI</a>
</p>


<p>
<a href="KEI.html#autosec-42" class="tocsection" >
<span class="sectionnumber">3.5</span>&#x2003;KEI</a>
</p>


<p>
<a href="Tilray.html#autosec-44" class="tocsection" >
<span class="sectionnumber">3.6</span>&#x2003;Tilray</a>
</p>


<p>
<a href="SBSW.html#autosec-46" class="tocsection" >
<span class="sectionnumber">3.7</span>&#x2003;SBSW</a>
</p>


<p>
<a href="US-Steel.html#autosec-48" class="tocsection" >
<span class="sectionnumber">3.8</span>&#x2003;US Steel</a>
</p>


<p>
<a href="Bloom-Health.html#autosec-52" class="tocsection" >
<span class="sectionnumber">3.9</span>&#x2003;Bloom Health</a>
</p>


<p>
<a href="NCI.html#autosec-54" class="tocsection" >
<span class="sectionnumber">3.10</span>&#x2003;NCI</a>
</p>


<p>
<a href="WWT.html#autosec-56" class="tocsection" >
<span class="sectionnumber">3.11</span>&#x2003;WWT</a>
</p>


<p>
<a href="Dole.html#autosec-58" class="tocsection" >
<span class="sectionnumber">3.12</span>&#x2003;Dole</a>
</p>


<p>
<a href="SEB.html#autosec-60" class="tocsection" >
<span class="sectionnumber">3.13</span>&#x2003;SEB</a>
</p>


<p>
<a href="Tech-log.html#autosec-62" class="tocsection" >
<span class="sectionnumber">3.14</span>&#x2003;Tech log</a>
</p>


<p>
<a href="Bibliography.html#autosec-65" class="tocchapter" >
Bibliography</a>
</p>


</div>

</nav>

</div>


<main class="bodycontainer">


<section class="textbody">

<h1>Stonk Research</h1>

<!--
...... section Bloom Health ......
-->
<h4 id="autosec-52"><span class="sectionnumber">3.9&#x2003;</span>Bloom Health</h4>
<a id="lwarp_template-autopage-52"></a>
<a id="lwarp_template-autofile-13"></a>

<p>
If it truly hits 325 million market cap, cad, sell the heck out of it, or the ebita numbers listed below.
</p>

<p>
As of May 31 2022
</p>

<p>
As for prices, seems undervalued if they can earn 900k * 3 = 2.7 million or 1.7 million, with growth and increasing margins, they have secured some funding for 2023 with the extension contract for testing.
</p>

<ul style="list-style-type:none">

<li>
<p>
• Revenue going pretty fast % 91 in a quarter is no joke
</p>


</li>
<li>


<p>
• stupid america policies, need an immediate solution for this to prove vaccinations
</p>


</li>
<li>


<p>
• trying to help out aging workforce.
</p>


</li>
<li>


<p>
• strong management.
</p>
</li>
</ul>

<p>
Disadvantages
</p>

<ul style="list-style-type:none">

<li>
<p>
• Covid based revenue, covid goes away sooner than expected (within a year or two)
</p>


</li>
<li>


<p>
• If ebitba milestones are hit, they are expected to hand over cash, but could still be a good thing.
</p>


</li>
<li>


<p>
• not enough money to meet obligations, expects to meet them their expansion in operations
</p>
</li>
</ul>

<p>
The Company’s current liabilities exceeded its current assets by &#x00024;2,971,565 as at March 31, 2022 (September 30, 2021 – &#x00024;5,069,219), which includes the fair value of the short-term consideration payable of &#x00024;9,956,467, based on the forecasted
timing of payments. As at March 31, 2022, the Company had cash on hand of &#x00024;1,680,144 (September 30, 2021 - &#x00024;5,598,296). The Company did not have sufficient cash to meet its current liabilities as at March 31, 2022, and expects to meet these
obligations with expansion in operations through 2022.
</p>

<p>
Payments to Round Hill
</p>

<p>
The members of Round Hill are also entitled to receive additional bonus payments (the “Contingent Consideration”) based upon the achievement of the following milestones:
</p>
<ul style="list-style-type:none">

<li>
<p>
• a one-time payment of US&#x00024;10,000,000, payable in cash or common shares of the Company, at the election of the members of Round Hill, upon Round Hill achieving cumulative EBITDA of at least US&#x00024;27,500,000 by December 31, 2023;
</p>


</li>
<li>


<p>
• a one-time payment of US&#x00024;20,000,000, payable in cash or common shares of the Company, at the election of the Company, upon the Company achieving a market capitalization of Cdn&#x00024;325,000,000 for thirty consecutive trading days prior to December
31, 2023; and
</p>


</li>
<li>


<p>
• a one-time payment of US&#x00024;20,000,000, payable in cash or common shares of the Company, at the election of the members of Round Hill, upon Round Hill achieving cumulative EBITDA of at least US&#x00024;52,500,000 by December 31, 2023.
</p>
</li>
</ul>

<p>
Evaluation, they project 25 to 28 million dollars revenue when revenue went up 91% in Q2, 16.9M total revenue, 8.4 million in booked revenue, projections 25-28, seems likely they will hit. Almost EBITDA positive.
</p>

</section>

</main>

</div>

<footer>

<p>
Contact: davidli012345@gmail.com - This is just my personal thoughts, all the reference I use should be cited.
</p>

</footer>


<nav class="botnavigation"><a href="lwarp_template.html" class="linkhome" >
Home</a></nav>

</body>
</html>
